Abstract
Fetomaternal hemorrhage (FMH) is a condition in which fetal blood enters the intervillous space of the maternal side due to damage or abnormality of the placental villi, resulting in anemia due to blood loss in the fetus. Depending on the volume of fetal blood into the maternal circulation, fetal and neonatal complications may vary. In severe cases, severe anemia and circulatory failure may occur, leading to sequelae and death. Since hydrops typically does not develop until the Hb deficit is >7 g/dL, severe fetal anemia is generally considered to be Hb <7 g/dL [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbasi N, Johnson JA, Ryan G. Fetal anemia. Ultrasound Obstet Gynecol. 2017;50:145–53.
Wylie BJ, D’Alton ME. Fetomaternal hemorrhage. Obstet Gynecol. 2010;115:1039–51.
Cunningham FG, Leveno KJ, Bloom SL, et al. Fetal disorders. In: Williams obstetrics. 25th ed. New York: McGraw-Hill; 2019. p. 300–14.
Lewis NE, Marszalek L, Ernst LM. Placental pathologic features in fetomaternal hemorrhage detected by flow cytometry. Pediatr Dev Pathol. 2017;20:142–51.
Stroustrup A, Plafkin C, Tran TA, et al. Demographic and behavioral predictors of severe fetomaternal hemorrhage: a case-control study. Neonatology. 2016;109:248–54.
Ghidini A, Korker V. Fetal complication after external cephalic version at term: case report and literature review. J Maternal Fetal Med. 1999;8:190–2.
She Q, Cheng Z, El-Chaar D, et al. Intraplacental choriocarcinoma coexisting with fetomaternal hemorrhage: case report, chemotherapy management, and literature review. Medicine. 2018;97:e9977.
Japan Council for Quality Health Care. 6th Report on prevention of recurrence, the Japan Obstetric Compensation System for Cerebral Palsy. Tokyo: Japan Council for Quality Health Care; 2016. Japanese.
Yamada T, Morikawa M, Yamada T, et al. Changes in hemoglobin F levels in pregnant women unaffected by clinical fetomaternal hemorrhage. Clin Chim Acta. 2013;415:124–7.
Tsuda H, Matsumoto M, Sutoh Y, et al. Massive fetomaternal hemorrhage. Int J Obstet Gynecol. 1995;50:47–9.
Maier JT, Schalinski E, Schneider W, et al. Fetomaternal hemorrhage, an update: review of the literature and an illustrative case. Arch Gynecol Obstet. 2015;292:595–602.
Hay DM, Forrester PI, Hancock RL, et al. Maternal serum alpha-fetoprotein in normal pregnancy. Br J Obstet Gynecol. 1976;83:534–8.
Khoo SK, Chang A, Mackay EV. A comparison of maternal serum levels of alpha-fetoprotein in normal and pre-eclamptic pregnancies. Br J Obstet Gynecol. 1978;85:914–20.
Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative group for doppler assessment of the blood velocity in anemic fetuses. N Engl J Med. 2000;342:9–14.
Bellussi F, Perolo A, Ghi T, et al. Diagnosis of severe fetomaternal hemorrhage with fetal cerebral doppler: case series and systematic review. Fetal Diag Ther. 2017;41:1–7.
Troia L, Al-Kouatly HB, McCurdy R, et al. The recurrence risk of fetomaternal hemorrhage. Fetal Diagn Ther. 2019;45:1–12.
Lindenburg ITM, van Kamp IL, Oepkes D. Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn Ther. 2014;36:263–71.
Van Klink JMM, Koopman HM, Oepkes D, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for fetal anemia. Early Hum Dev. 2011;87:589–93.
Korteweg FJ, Erwich JJHM, Timmer A, et al. Evaluation of 1025 fetal deaths: a proposed diagnostic workup. Am J Obstet Gynecol. 2012;206(53):e1–12.
O’Leary BD, Walsh CA, Fitzgerald JM, et al. The contribution of massive fetomaternal hemorrhage to antepartum stillbirth: a 25-year cross- sectional study. Acta Obstet Gynecol Scand. 2015;94:1354–8.
Rubod C, Deruele P, Goueff FL, et al. Long-term prognosis for infants after massive fetomaternal hemorrhage. Obstet Gynecol. 2007;110:256–60.
Tagaya M, Fujimaki H, Shimizu S, et al. Brain damage caused by severe fetomaternal hemorrhage. Pediatr Int. 2010;52:301–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mitani, M., Matsuda, Y. (2022). Fetomaternal Hemorrhage. In: Matsuda, Y. (eds) Cerebral Palsy. Springer, Singapore. https://doi.org/10.1007/978-981-19-2217-6_18
Download citation
DOI: https://doi.org/10.1007/978-981-19-2217-6_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-2216-9
Online ISBN: 978-981-19-2217-6
eBook Packages: MedicineMedicine (R0)